Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart Transplantation

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1356
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Idarucizumab for Urgent Reversal of Dabigatran for Heart Transplant: A Case Report

American Journal of Hematology
Hematology
2017English

Idarucizumab Dosing in Patients With Excessive Dabigatran Body Burden

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2019English

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke

Frontiers in Neurology
Neurology
2019English

Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis

Journal of Neurology
Neurology
2017English

Successful Intravenous Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Anticoagulation With Idarucizumab: A Case Report

Journal of Medical Case Reports
Medicine
2017English

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study

Cardiology and Therapy
2020English

126 Risk Stratification of Ambulatory Patients With Advanced Heart Failure Undergoing Evaluation for Heart Transplantation

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2012English

Antigens of persistentChlamydia Pneumoniaewithin Coronary Atheroma From Patients Undergoing Heart Transplantation

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2011English

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy